Over the last 7 days, the market has remained flat, but it is up 32% over the past year with earnings forecast to grow by 15% annually. In this environment, identifying high growth tech stocks that can capitalize on these trends is crucial for investors seeking robust returns.
Zai Lab Limited (ZLAB) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
SHANGHAI & CAMBRIDGE, Mass., September 17, 2024--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688; "Zai Lab") today announced that data from a preclinical study of ZL-1503, the company’s internally discovered IL-13/IL-31 bispecific antibody for the treatment of atopic dermatitis (AD), will be presented in a late-breaking oral presentation at the European Academy of Dermatology and Venerology Congress (EADV) 2024 taking place September 25-28 in Amsterdam, Netherlands. The results will address the potent